As of 4:00pm ET
| -0.46 / -2.90%|
The 8 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 23.00, with a high estimate of 33.00 and a low estimate of 11.50. The median estimate represents a +49.35% increase from the last price of 15.40.
The current consensus among 9 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.